[Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
In a 70-year-old patient with sotalol-induced torsade de pointes, QT-dispersion in the 12-lead surface ECG was determined in an attempt to evaluate the role of this method in determining risk factors for the development of proarrhythmic effects. After recovery from torsade, the patient was successfully treated with amiodarone over a 3-month follow-up period. Whereas the degree of QT prolongation was comparable during amiodarone therapy to that observed with sotalol, QT dispersion was markedly less (47 ms) than during previous treatment with sotalol (77 ms). During drug-free control, QT dispersion was 43 ms. This case-report indicates that determination of QT dispersion can provide information with respect to identification of patients prone to class III antiarrhythmic drug-induced proarrhythmic effects.
van de Loo
A
A
Medizinische Universitätsklinik III, Kardiologie, Freiburg.
Klingenheben
T
T
Hohnloser
S H
SH
D000368:Aged; D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use*; D015716:Electrocardiography, Ambulatory / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000188:drug therapy; D016171:Torsades de Pointes / Q000139:chemically induced* / Q000188:drug therapy
D000638:Amiodarone
Amiodarontherapie nach Sotalol-induzierter Torsade de pointes: QT-Verlängerung und QT-Dispersion zur Differenzierung proarrhythmischer Effekte.